Orphinic Scientific is a drug development and investment company that specializes in creating innovative therapies for orphan diseases. The firm targets mid-market opportunities, concentrating on late preclinical research and Phase 1/2 clinical trials. By focusing on high-quality assets in rare diseases and other areas with significant unmet medical needs, Orphinic aims to provide its clients with ready-to-manufacture medical technologies. The company's platform is designed to facilitate the development and investment in promising medical solutions, addressing critical gaps in treatment for patients suffering from these rare conditions.
Vasa Therapeutics is a privately held biopharmaceutical company based in Encinitas, California, focused on developing therapies for vascular diseases. The company specializes in the discovery and development of treatments for conditions such as heart failure, peripheral artery disease, and sarcopenia. Vasa Therapeutics utilizes an in-house drug discovery testing funnel to identify promising small molecule and peptide therapeutics, aiming to provide healthcare professionals with effective options for managing these significant health issues.
Ambulero
Seed Round in 2021
Ambulero, Inc is a biotechnology company that emerged as a spin-out from the University of Miami, concentrating on the development of innovative therapies for vascular diseases. The company specializes in cell and gene therapy, utilizing various cell and synthetic vector technologies to deliver adhesion molecules. This approach aims to significantly improve the healing of damaged limbs, offering more effective treatment options compared to traditional methods. By focusing on advancing new therapies, Ambulero seeks to address critical healthcare challenges associated with vascular tissue disease.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.